Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of eplerenone on glucose metabolism and blood pressure in hypertensive patients with obesity

Trial Profile

Effects of eplerenone on glucose metabolism and blood pressure in hypertensive patients with obesity

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Eplerenone (Primary) ; Trichlormethiazide
  • Indications Hypertension
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 24 Apr 2019 Status changed from active, no longer recruiting to completed.
    • 20 Apr 2016 Status changed from recruiting to active, no longer recruiting.
    • 17 Apr 2015 According to UMIN, the date for data entry closure is 2016/12/31, and the date for conclusion of data analysis is 2017/02/28.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top